Generalized anxiety disorder in family practice patients.
Magill
M K
MK
Gunning
K
K
D014151:Anti-Anxiety Agents / Q000627:therapeutic use; D001008:Anxiety Disorders / Q000150:complications / Q000175:diagnosis / Q000188:drug therapy; D001569:Benzodiazepines; D002065:Buspirone / Q000627:therapeutic use; D003511:Cyclohexanols / Q000627:therapeutic use; D003863:Depression / Q000150:complications / Q000175:diagnosis; D003937:Diagnosis, Differential; D005194:Family Practice; D006801:Humans; D017366:Serotonin Receptor Agonists / Q000627:therapeutic use; D017367:Selective Serotonin Reuptake Inhibitors / Q000627:therapeutic use; D014481:United States; D000069470:Venlafaxine Hydrochloride
D014151:Anti-Anxiety Agents; D001569:Benzodiazepines; D002065:Buspirone; D003511:Cyclohexanols; D017366:Serotonin Receptor Agonists; D017367:Selective Serotonin Reuptake Inhibitors; D000069470:Venlafaxine Hydrochloride